Create Alert
Watchlist

RPG Life Sciences

₹2,316.40
+10.70 (0.46%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
2,290.00
Prev. Close
2,305.70
Volume
5,767
Total traded value
1.34 Cr
Upper Circuit
2,779.60
Lower Circuit
1,853.20

Fundamentals

Market Cap₹3,817Cr
ROE20.12%
P/E Ratio(TTM)17.72
EPS(TTM)130.25
P/B Ratio6.89
Dividend Yield1.04%
Industry P/E40.17
Book Value334.94
Debt to Equity0.00
Face Value8
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About RPG Life Sciences

RPG Life Sciences is a research-based, integrated pharmaceutical company that operates in domestic and international markets, providing quality and affordable medicines across various therapeutic areas. Its primary objective is to foster an agile, intelligent, and performance-driven culture centered on the transformative power of 'Building a Healthier Tomorrow, Together'. The firm focuses on expanding its product line and strengthening research and development efforts to ensure a consistent supply of life-saving medications for patients. Its business activities are organized into three key segments: Domestic Formulations, International Formulations, and Active Pharmaceutical Ingredients (APIs) to serve diverse medical needs. Internationally, the business develops and markets oral solid formulations for both generic and branded generic markets, with a strong focus on the Immunosuppressant segment. As a recognized leader in the Immunosuppressant drug category, the company has also developed six 'Text Book Brands' that are widely trusted by doctors.;
Parent OrganisationRPG Life Sciences Limited
Managing DirectorAshok Nair
NSE SymbolRPGLIFE

Shareholding Pattern

Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Promoters
72.95%
Retail And Others
19.24%
Other Domestic Institutions
3.49%
Mutual Funds
3.20%
Foreign Institutions
1.11%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
JB Chemicals & Pharmaceuticals
NA
(0.00%)
39.25
Emcure Pharmaceuticals
NA
(0.00%)
33.30
Wockhardt
NA
(0.00%)
-427.29
Cohance Lifesciences
NA
(0.00%)
65.51
2025
17
Oct
Quarterly Result
Release date
25
Jul
Quarterly Result
Release date

27
Jun
Dividend
Ex date
₹4.00
per share

For each share you hold, you will receive ₹4.00
Dividend amount₹4.00 per share
Dividend TypeSpecial
Ex Date27 Jun ‘25
Record Date27 Jun ‘25
Announcement date28 Apr ‘25

27
Jun
Dividend
Ex date
₹20.00
per share

For each share you hold, you will receive ₹20.00
Dividend amount₹20.00 per share
Dividend TypeFinal
Ex Date27 Jun ‘25
Record Date27 Jun ‘25
Announcement date28 Apr ‘25

28
Apr
Dividend
Announced
₹4.00
per share

For each share you hold, you will receive ₹4.00
Dividend amount₹4.00 per share
Dividend TypeSpecial
Ex Date27 Jun ‘25
Record Date27 Jun ‘25
Announcement date28 Apr ‘25

28
Apr
Dividend
Announced
₹20.00
per share

For each share you hold, you will receive ₹20.00
Dividend amount₹20.00 per share
Dividend TypeFinal
Ex Date27 Jun ‘25
Record Date27 Jun ‘25
Announcement date28 Apr ‘25
28
Apr
Annual Result
Release date
24
Jan
Quarterly Result
Release date
2024
7
Nov
Quarterly Result
Release date
19
Jul
Quarterly Result
Release date

28
Jun
Dividend
Ex date
₹16.00
per share

For each share you hold, you will receive ₹16.00
Dividend amount₹16.00 per share
Dividend TypeFinal
Ex Date28 Jun ‘24
Record Date28 Jun ‘24
Announcement date30 Apr ‘24

30
Apr
Dividend
Announced
₹16.00
per share

For each share you hold, you will receive ₹16.00
Dividend amount₹16.00 per share
Dividend TypeFinal
Ex Date28 Jun ‘24
Record Date28 Jun ‘24
Announcement date30 Apr ‘24
30
Apr
Annual Result
Release date
Events calendar
View upcoming events in other stocks